Regulatory
Regulatory Articles
Regulatory updates and compliance
Sort by date:
Florida HB 1617 - Stem Cell Therapy Authorization
Florida HB 1617 authorizes physicians to perform FDA-unapproved stem cell therapy with specific requirements for manufacturing practices, patient consent, and advertising disclosures. Effective July 1, 2025.
Montana SB535 - Experimental Treatment Centers Licensing
Montana Legislative Bill LC0780/SB535 establishes frameworks for experimental treatment centers, providing pathways for innovative medical treatments including regenerative therapies under controlled conditions.
Utah SB0199 - Placental Tissue Therapy Authorization
Utah Senate Bill SB0199 introduces amendments to existing regulations regarding placental tissue use in medical treatments, clarifying legal frameworks for regenerative medicine applications.
FSMB Guidelines for Regenerative Medicine Practices
The Federation of State Medical Boards provides comprehensive guidelines for regenerative therapy practices, establishing standards for physician training, patient safety, and regulatory compliance across state medical boards.
New Hampshire HB701 - Expanded Right to Try Act
New Hampshire House Bill 701 establishes the Terminal Patients' Right to Try Act, providing legal pathways for terminally ill patients to access experimental treatments including regenerative therapies.